Immunocore Holdings (IMCR) Non-Current Assets (2019 - 2026)

Immunocore Holdings' (IMCR) quarterly Non-Current Assets came in at $68.3 million in Q1 2026, down 13.98% year-on-year from $79.4 million in Q1 2025, and up 712.95% quarter-over-quarter from $8.4 million in Q4 2025.

Immunocore Holdings (IMCR) Non-Current Assets (2019 - 2026) Analysis & Trends

Immunocore Holdings has disclosed Non-Current Assets across 8 years of filings, most recently posting $68.3 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $68.3 million, down 13.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $307.4 million (up 5.07% YoY), and the FY2025 annual result was $8.4 million, down 84.97% from the prior year.
  • Non-Current Assets came in at $68.3 million for Q1 2026 at Immunocore Holdings, up from $8.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $80.1 million in Q2 2025 to a low of $8.4 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $67.9 million (2024), against an average of $62.9 million.
  • Peak annual rise in Non-Current Assets reached 20.42% in 2025, while the deepest fall reached 84.97% in 2025.
  • Immunocore Holdings' Non-Current Assets stood at $51.2 million in 2022, then climbed by 8.24% to $55.4 million in 2023, then gained by 0.9% to $55.9 million in 2024, then tumbled by 84.97% to $8.4 million in 2025, then jumped by 712.95% to $68.3 million in 2026.
  • The last three Non-Current Assets figures came in at $68.3 million (Q1 2026), $8.4 million (Q4 2025), and $79.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 62,953.78
2 Belite Bio 55,234.00 Bn 55,234.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn - 4.56 Mn
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn - 30.30 Mn
6 Evaxion A 1,540.85 Bn 1,540.84 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn 14.75 Bn
9 Abivax 93.46 Bn 93.46 Bn - 39.71 Mn
10 Immunocore Holdings 1.46 Bn 616.35 Mn 106.24 Mn 68.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.29 Mn
Dec 31, 2025 8.40 Mn
Sep 30, 2025 79.65 Mn
Jun 30, 2025 80.09 Mn
Mar 31, 2025 79.38 Mn
Dec 31, 2024 55.90 Mn
Sep 30, 2024 78.73 Mn
Jun 30, 2024 66.51 Mn
Mar 31, 2024 67.95 Mn
Dec 31, 2023 55.40 Mn
Dec 31, 2022 51.18 Mn
Dec 31, 2021 52.64 Mn
Dec 31, 2020 58.45 Mn
Dec 31, 2019 78.90 Mn